Clinical trialNCT06534060RecruitingPhase 2Interventional

MB-105 in Patients With CD5 Positive T-cell Lymphoma

SponsorMarch Biosciences IncEnrollment46Lymphoma, T-Cell

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Alice Bexon, MD, CMO
March Bio
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of San Diego (ucsd)-Moores Cancer Center
San Diego, California, United States
Aaron Goodman, MD
Recruiting
Scri - Colorado Blood Cancer Institute (cbci)
Denver, Colorado, United States
Not, yet, recruiting
Moffitt Cancer Center Magnolia Campus
Tampa, Florida, United States
Alexandr Lazaryan, MD
Recruiting
University of Iowa
Iowa City, Iowa, United States
Eric Mou, MD
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Salvia Jain, MD
Recruiting
University of Nebraska
Omaha, Nebraska, United States
Julie Vose, MD
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Steven Horwitz, MD
Recruiting
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Anne Beaven, MD
Recruiting
Cleveland Clinic
Cleveland, Ohio, United States
Deepa Jagadeesh, MD
Not, yet, recruiting
Oregan Health & Science University
Portland, Oregon, United States
Andy Chen, MD
Not, yet, recruiting
Baylor College of Medicine
Houston, Texas, United States
LaQuisa Hill, MD
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Swaminathan P. Iyer, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 15 Feb 2025
Primary completion: 29 Feb 2028
Completion: 31 Dec 2029
Last update posted: 3 Oct 2025
Registered enrollment: 46
Registry id: NCT06534060

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.